Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Autor: Palma-Álvarez, Raul Felipe, Barta, Csaba, Carpentier, Pieter Jan, Carruthers, Susan, Crunelle, Cleo L., Demetrovics, Zsolt, Dom, Geert, Faraone, Stephen V., Franck, Johan, Johnson, Brian, Kapitány-Fövény, Máté, Kaye, Sharlene, Konstenius, Maija, Matthys, Frieda, Moggi, Franz, Møller, Merete, Schellekens, Arnt, Skutle, Arvid, Van De Glind, Geurt, Van Emmerik-Van Oortmerssen, Katelijne, Verspreet, Sofie, Schoevers, Robert A., Wallhed, Sara, Levin, Frances R., Grau-López, Lara, Casas, Miguel, Van Den Brink, Wim, Ramos-Quiroga, Josep Antoni
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Palma-Álvarez, Raul Felipe; Barta, Csaba; Carpentier, Pieter Jan; Carruthers, Susan; Crunelle, Cleo L.; Demetrovics, Zsolt; Dom, Geert; Faraone, Stephen V.; Franck, Johan; Johnson, Brian; Kapitány-Fövény, Máté; Kaye, Sharlene; Konstenius, Maija; Matthys, Frieda; Moggi, Franz; Møller, Merete; Schellekens, Arnt; Skutle, Arvid; van de Glind, Geurt; van Emmerik-van Oortmerssen, Katelijne; ... (2020). Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus (In Press). Revista de Psiquiatría y Salud Mental Elsevier España 10.1016/j.rpsm.2020.04.013
Popis: Objective: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion. Method: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus. Results: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60. Conclusion: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients. Scientific significance: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.
Databáze: OpenAIRE